Molecular events in hepatic preneoplasia: A review

Experimental and Molecular Pathology

Volumn 88, Issue 2, 2010, Pages 219-224

  French, S W ^a  

^a HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

Dysplastic foci; Liver stem cells; Microarrays; Progenitor cells

Indexed keywords

AURORA A KINASE; BETA CATENIN; FATTY ACID SYNTHASE; FRIZZLED PROTEIN; GAMMA GLUTAMYLTRANSFERASE; GLUTATHIONE TRANSFERASE; HEAT SHOCK PROTEIN 70; TRANSFORMING GROWTH FACTOR BETA; WNT PROTEIN;

CPG ISLAND; DNA METHYLATION; FATTY ACID METABOLISM; GENE EXPRESSION; HUMAN; IN SITU HYBRIDIZATION; LIPID METABOLISM; LIVER CANCER; LIVER CIRRHOSIS; MICROARRAY ANALYSIS; NONHUMAN; PHENOTYPE; PRECANCER; PROTEIN LOCALIZATION; REVIEW;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL TRANSFORMATION, NEOPLASTIC; DISEASE MODELS, ANIMAL; DYSPLASTIC NEVUS SYNDROME; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER; LIVER DISEASES; LIVER NEOPLASMS; PRECANCEROUS CONDITIONS; UBIQUITINS;

EID: 77950691752     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2010.01.005     Document Type: Review

References (60)

1. Abdul-Al H.M., Makhlou H.R., Wang G., et al. Glypican-3 expression in benign liver tissue with active hepatitis C: implications for the diagnosis of hepatocellular carcinoma. Human Pathol. 2008, 39:209-212.
2. Apte U., Thompson M.D., Cui S., et al. Wnt/β-catenin signaling mediates oval cell response in rodents. Hepatology 2008, 47:288-295.
3. Bagnyukova T.V., Tryndyak V.P., Muskhelishvilli L., et al. Epigenetic downregulation of the suppressor of cytokine signaling 1 (Socs 1) gene is associated with the STAT3 activation and development of hepatocellular carcinoma induced by methyl-deficiency in rats. Cell Cycl. 2008, 7:3202-3210.
4. Bardag-Gorce F., Oliva J., Villegas J., et al. Epigenetic mechanisms regulate Mallory Denk body formation in the livers of drug-primed mice. Exp. Mol. Pathol. 2008, 94:113-121.
5. Braconi C., Patel T. MicroRNA expression profiling: A molecular tool for defining the phenotype of hepatocellular tumors. Hepatology 2008, 47:1807-1809.
6. Chen Y.-W., Jeng Y.-M., Yeh S.-H., et al. p53 gene and Wnt signaling in benign neoplasms: Catenin mutations in hepatic adenoma but not in focal nodular hyperplasia. Hepatology 2002, 36:927-935.
7. Cieply B., Zehg G., Proverbs-Singh T., et al. Unique phenotype of hepatocellular cancers with exon-3 mutations in beta-catenin gene. Hepatology 2009, 49:821-831.
8. Croager E.J., Smith P.G.J., Yeoh G.C.T. Ethanol interactions with a choline-deficient, ethionine-supplemented feeding regime potentiate pre-neoplsatic cellular alterations in rat liver. Carcinogenesis 2002, 23:1685-1693.
9. Desmet V.J. East-West pathology agreement on precancerous liver lesions and early hepatocelluar carcinoma. Hepatology 2009, 49:355-357.
10. Di Tommaso L., Franchi G., Park Y.N., et al. Diagnostic value of HSP70, glypican3 and glutamine synthetase in hepatocellular nodules in cirrhosis. Hepatology 2007, 45:725-734.
11. Evert M., Schneider-Stock R., Dombrowski F. Overexpression of fatty acid synthase in chemically and hormonally induced hepatocarcinogenesis of the rat. Lab. Invest. 2005, 85:99-108.
12. Fan Y., Shimizu T., Yamada T., et al. Development of glutathione S-transferase-P-negative foci accompanying nuclear factor-erythroid 2-related factor 2 expression during early state of rat hepatocarcinogenesis. Cancer Sci. 2008, 99:497-501.
13. Farazi P.A., Glickman J., Jiang S., et al. Differential impact of telemere dysfunction on initiation and progression of hepatocellular carcinoma. Cancer Res. 2003, 63:5021-5027.
14. Farber E. Clonal adaptation during carcinogenesis. Biochem. Pharmacol. 1990, 39:1837-1846.
15. Feo F., Frau M., Tomasi M.L., et al. Genetic and epigenetic control of molecular alternations in hepatocellular carcinoma. Exp. Biol. Med. 2009, 234:726-736.
16. Inoue K., Shibutani M., Masutomi N., et al. One year chronic toxicity of madden color in F344 rats. Induction of preneoplastic/neoplastic lesions in the kidney and liver. Food Chem. Toxicol. 2008, 46:3303-3310.
17. Pathology diagnosis of early hepatocellular carcinoma: A report of the international concensus group for hepatocellular neoplasia. Hepatology 2009, 49:658-664. International Consensus Group for Hepatocellular Neoplasms.
18. Kojiro M. Pathology of hepatocellular carcinoma 2006, Blackwell Publishing Ltd., Oxford.
19. Kojiro M., Roskams T. Early hepatocellular carcinoma and dysplasia nodules. Semin. Liver Dis. 2005, 25:133-142.
20. Laconi E. Differentiatial growth: from carcinogenesis to liver repopulation. Am. J. Pathol. 2000, 156:389-392.
21. Lee S., Lee H.J., Kim J.-H., et al. Aberrant CpG island hypermethylation along multistep hepatocarcinogenesis. Am. J. Pathol. 2003, 163:1371-1378.
22. Lee C.G., Ren J., Cheong I.S., et al. Expression of the FAT10 gene is highly upregulated in hepatocellular carcinoma and other gastrointestinal and gynecological cancers. Oncogene 2003, 22:2592-2603.
23. Li J., Bardag-Gorce F., Dedes J., et al. S-adenosylmethionine prevents Mallory Denk body formation in drug-primed mice by inhibiting epigenetic memory. Hepatology 2008, 47:613-624.
24. Libbrecht L. Hepatic progenitor cells in human liver tumor development. World J. Gastroenterol. 2006, 12:6261-6265.
25. Llovet J.M., Chen Y., Wurmbach E., et al. A molecular signature to descriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis. Gastroenterology 2006, 131:1758-1767.
26. Lu S.C., Ramani K., Ou X., et al. S-adenosylmethionine in the chemoprevention and treatment of hepatocellular carcinoma in a rat model. Hepatology 2009, 50:462-471.
27. Lukasiak S., Schiller C., Oehischlaeger P., et al. Proinflammatory cytokines cause FAT10 upregulation in cancers of the liver and colon. Oncogene 2008, 27:6068-6074.
28. Machida K., Tsukamoto H., Mkrtch H., et al. Toll-like receptor 4 mediates synergism between alcohol and HCV in hepatic oncogenesis involving stem cell markers Namog. PNAS 2009, 106:1548-1553.
29. Metodieva S.N. Molecular pathogenesis of hepatocellular carcinoma. Balkan J. Med. Genet. 2008, 10:15-22.
30. Mishra L., Banker T., Murray J., et al. Liver stem cells and hepatocellular carcinoma. Hepatology 2009, 49:318-329.
31. Monga S.P.S. Hepatic adenomas: presumed innocent until proven to be beta-catenin mutate. Hepatology 2006, 43:401-404.
32. Mosimann C., Hausmann G., Basier K. β-Catenin histochromatin: regulation of Wnt target gene activation. Nat. Rev. Mol. Cell. Biol. 2009, 10:276-286.
33. Murrai T., Mori S., Kang J.S., et al. Evidence of a threshold for 2-amino-3, 8-dimethylimidazo-[4, 5-f] quinoxaline liver carcinogenicity in F344/DuCrj rats. Toxicol. Pathol. 2008, 36:472-477.
34. Nagao Y., Yuan Q.-X., Wan Y-J Y., et al. Pathogenesis of Mallory body formation: Studies using the drug-primed mouse model. Hepatol. Res. 1998, 13:42-54.
35. Nagao Y., Wan Y-J Y., Yuan Q.X., et al. Mouse model of hepatocellular hyperplastic nodule formation characterization of mRNA expression. Hepatol. Res. 1999, 15:110-123.
36. Nam S.W., Park J.Y., Ramasamy A., et al. Molecular changes from dysplastic nodule to hepatocellular carcinoma through gene expression profiling. Hepatology 2005, 42:809-818.
37. Nan L., Bardag-Gorce F., Wu Y., et al. Mallory body forming cells express the preneoplastic hepatocyte phenotype. Exp. Mol. Pathol. 2006, 80:109-118.
38. Nishimura J., Dewa Y., Okamura T., et al. Possible involvement of oxidative stress in fenofibrate-induced hepatocarcinogenesis in rats. Arch. Toxicol. 2008, 82:641-654.
39. Oliva J., Bardag-Gorce F., French B.A., et al. FAT10 is an epigenetic marker for liver preneoplasia in a drug-primed mouse model of tumorigenesis. Exp. Mol. Pathol. 2008, 84:102-112.
40. Oliva J., Bardag-Gorce F., Li J., et al. Betaine prevents Mallory-Denk body formation in drug-primed mice by epigenetic mechanisms. Exp. Mol. Pathol. 2009, 86:77-86.
41. Pascale R.M., Simile M.M., DeMiglio M.R., et al. Chemoprotection of hepatocarcinogenesis: S-adenosyl-L-methionine. Alcohol 2002, 27:193-198.
42. Perra A., Kowalik M.A., Pibiri M., et al. Thyroid hormone receptor ligands induce regression of rat preneoplastic liver lesions causing their reversion to a differentiated phenotype. Hepatology 2009, 49:1287-1296.
43. Petersen B.E. Hepatic "stem" cells: coming full circle. Blood Cells Mol. Dis. 2001, 27:590-600.
44. Ren J., Kan A., Leong S.H., et al. FAT10 plays a role in the regulation of chromosomal stability. J. Biol. Chem. 2006, 281:11413-11421.
45. Roncalli M., Borzio M., Di Tommaso L. Hepatocellular dysplastic nodules. Hepatol. Res. 2007, 37(Suppl 2):S125-S134.
46. Roomi M.W., Gaal K., Yuan Q.X., et al. Preneoplastic liver cell foci induced by thioacetamide toxicity in drug primed liver. Exp. Mol. Pathol. 2006, 81:8-14.
47. Sakamoto M. Early HCC: Diagnosis and molecular markers. J. Gastroenterol. 2009, 44(Suppl XIX):108-111.
48. Satoh K., Yamakawa D., Sugio H., et al. Bile duct-bound growth of precursor cells of preneoplastic foci inducible in the initiation stage of rat chemical hepatocarcinogenesis by Z-acetylminofluorene. Jpn. J. Clin. Oncol. 2008, 38:604-610.
49. Sawan C., Vaissiere T., Murr R., et al. Epigenetic drivers and genetic passengers on the road to cancer. Mutat. Res. 2008, 642:1-13.
50. Scolastici C., Lopes G.A.D., Barbisan L.F., et al. Tomato oleoresin inhibits DNA damage but not diethylnitrosamine-induced rat hepatocarcinogenesis. Exp. Toxicol. Pathol. 2008, 60:59-68.
51. Sell S. Alpha-fetoprotein, stem cells and cancer: How study of the production of alpha-fetoprotein during chemical hepatocarcinogenesis led to reaffirmation of the stem cell theory of cancer. Tumor Biol. Biol. 2008, 29:161-180.
52. Solt D.B., Medline A., Farber E. Rapid emergence of carcinogen-induced hyperplastic lesions in a new model for the sequential analysis of liver carcinogenesis. Am. J. Pathol. 1977, 88:595-618.
53. Sukata T., Uwagawa S., Ozaki K., et al. α2-macroglobulin: A novel cytochemical marker characterizing preneoplastic and neoplastic rat liver lesions negative for hitherto established cytochemical markers. Am. J. Pathol. 2004, 165:1479-1488.
54. Sun S., Zhang X., Locke J.E., et al. Recruitment of host progenitor cells in rat liver transplants. Hepatology 2009, 49:587-597.
55. Tazawa J., Irie T., French S.W. Mallory body formation is linked to gamma glutamyl transferase induction in hepatocytes of griseofulvin-fed mice. Hepatology 1983, 3:989-1001.
56. Teoh N.C., Dan Y.Y., Swisshelm K., et al. Defective DNA strand break repair causes chromosomal instability and accelerates liver carcinogenesis in mice. Hepatology 2008, 47:2078-2088.
57. Thorgeirson S.S., Grisham J.W. Hematopoietic cells as hepatocyte stem cells: A critical review of the evidence. Hepatology 2006, 43:2-8.
58. Villanueva A., Nowell P., Chang D.Y., et al. Genomics and signaling pathway in hepatocellular carcinoma. Semin. Liver Dis. 2007, 27:55-76.
59. Wurmbach E., Chen Y.-B., Knitrov G., et al. Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma. Hepatology 2007, 45:938-947.
60. Xiao J.-C., Ruck P., Adam A., et al. Small epithelial cells in human liver cirrhosis exhibit features of hepatic stem cells in human liver cirrhosis exhibit features of hepatic stem-like cells: immunohistochemical, electron microscopic and immunoelectron microscopic findings. Histopathology 2003, 42:141-149.